Therefore, to further understand the therapeutic mechanism of CASR in the treatment of CHD, we tested a hypothesis that CASR regulates lipid metabolism and improves myocardial infarction through its constituents in the plasma, to treat CHD. The gene discussed is CASR; the disease is myocardial infarction.